Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia - PubMed (original) (raw)
doi: 10.1038/sj.leu.2403263.
V H J van der Velden, T Raff, J Droese, M Ritgen, C Pott, A J Wijkhuijs, N Gökbuget, D Hoelzer, E R van Wering, J J M van Dongen, M Kneba
Affiliations
- PMID: 14961040
- DOI: 10.1038/sj.leu.2403263
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia
M Brüggemann et al. Leukemia. 2004 Apr.
Abstract
Current MRD studies in T-cell acute lymphoblastic leukemia (T-ALL) mainly use T-cell receptor gamma, delta and SIL-TAL1 gene rearrangements as MRD-PCR targets. However, low frequency or limited diversity of these markers restricts the number of evaluable patients, particularly because two markers are recommended for MRD monitoring. Hence, we developed a new strategy implementing the TCR beta (TCRB) locus for MRD quantification. The frequency and characteristics of complete and incomplete TCRB rearrangements were investigated in 53 childhood and 100 adult T-ALL patients using the BIOMED-2 multiplex PCR assay. Clonal rearrangements were identified in 92% both childhood and adult T-ALL (Vbeta-Dbeta-Jbeta rearrangements in 80%, Dbeta-Jbeta rearrangements in 53%). Comparative sequence analysis of 203 TCRB recombinations revealed preferential usage of the 'end-stage' segment Jbeta2.7 in childhood T-ALL (27%), whereas Jbeta2.3 was most frequently involved in adult T-ALL (24%). In complete rearrangements, three downstream Vbeta segments (19-1/20-1/21-1) were preferentially used. Subsequently, a TCRB real-time quantitative PCR assay to quantify MRD with 13 germline Jbeta primer/probe combinations and allele-specific oligonucleotides was developed and applied to 60 clonal TCRB rearrangements. The assay allowed the detection of one leukemic cell within at least 10(4) polyclonal cells in 93% of cases and will be of high value for future MRD studies.
Similar articles
- TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse.
van der Velden VH, Brüggemann M, Hoogeveen PG, de Bie M, Hart PG, Raff T, Pfeifer H, Lüschen S, Szczepański T, van Wering ER, Kneba M, van Dongen JJ. van der Velden VH, et al. Leukemia. 2004 Dec;18(12):1971-80. doi: 10.1038/sj.leu.2403505. Leukemia. 2004. PMID: 15470492 - Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies.
Droese J, Langerak AW, Groenen PJ, Brüggemann M, Neumann P, Wolvers-Tettero IL, van Altena MC, Kneba M, van Dongen JJ. Droese J, et al. Leukemia. 2004 Sep;18(9):1531-8. doi: 10.1038/sj.leu.2403428. Leukemia. 2004. PMID: 15284865 - Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.
Szczepański T, Flohr T, van der Velden VH, Bartram CR, van Dongen JJ. Szczepański T, et al. Best Pract Res Clin Haematol. 2002 Mar;15(1):37-57. doi: 10.1053/beha.2002.0184. Best Pract Res Clin Haematol. 2002. PMID: 11987915 Review. - Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. van Dongen JJ, et al. Leukemia. 2003 Dec;17(12):2257-317. doi: 10.1038/sj.leu.2403202. Leukemia. 2003. PMID: 14671650 Review.
Cited by
- iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests.
Themeli M, Chhatta A, Boersma H, Prins HJ, Cordes M, de Wilt E, Farahani AS, Vandekerckhove B, van der Burg M, Hoeben RC, Staal FJT, Mikkers HMM. Themeli M, et al. Stem Cell Reports. 2020 Feb 11;14(2):300-311. doi: 10.1016/j.stemcr.2019.12.010. Epub 2020 Jan 16. Stem Cell Reports. 2020. PMID: 31956083 Free PMC article. - Evolution of Tumor Clones in Adult Acute Lymphoblastic Leukemia.
Smirnova SY, Sidorova YV, Ryzhikova NV, Sychevskaya KA, Parovichnikova EN, Sudarikov AB. Smirnova SY, et al. Acta Naturae. 2016 Oct-Dec;8(4):100-109. Acta Naturae. 2016. PMID: 28050271 Free PMC article. - Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic Cells.
Kotrova M, Darzentas N, Pott C, Baldus CD, Brüggemann M. Kotrova M, et al. Genes (Basel). 2021 Jun 27;12(7):979. doi: 10.3390/genes12070979. Genes (Basel). 2021. PMID: 34198966 Free PMC article. Review. - Current Strategies for the Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
Rocha JM, Xavier SG, de Lima Souza ME, Assumpção JG, Murao M, de Oliveira BM. Rocha JM, et al. Mediterr J Hematol Infect Dis. 2016 Apr 10;8(1):e2016024. doi: 10.4084/MJHID.2016.024. eCollection 2016. Mediterr J Hematol Infect Dis. 2016. PMID: 27158437 Free PMC article. Review. - Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL.
Dourthe ME, Courtois L, Andrieu GP, Simonin M, Touzart A, Lhermitte L, Petit A, Boissel N, Baruchel A, Asnafi V, Macintyre E. Dourthe ME, et al. Hemasphere. 2023 Mar 17;7(4):e871. doi: 10.1097/HS9.0000000000000871. eCollection 2023 Apr. Hemasphere. 2023. PMID: 36950021 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources